Syri Limited Recalls Baclofen 10mg/5ml Oral Solution Due to Crystallisation Concerns

What Happened

Syri Limited, trading as SyriMed, has initiated a Class 2 medicines recall for Baclofen 10mg/5ml Oral Solution. This precautionary action follows reports of crystallisation occurring in the oral solution over time.

Which Products Are Affected

The recall involves the following pharmaceutical product:

• Product Name: Baclofen 10mg/5ml Oral Solution
• Manufacturer: Syri Limited, T/A SyriMed
• Recall Reference: EL(26)A/06
• Alert Class: Class 2 Recall

The recall affects specific batches of the product where crystallisation has been observed.

What You Should Do

Healthcare professionals and patients are advised to check their stock for the affected medication. If you have the product, you should follow the guidance provided in the official MHRA alert regarding the quarantine and return of affected batches. For further information, consumers can contact SyriMed or refer to the official government notice.

Why This Matters

Crystallisation in an oral solution can lead to an uneven distribution of the active ingredient, potentially resulting in incorrect dosing or reduced efficacy for the patient.

Source

MHRA (Medicines and Healthcare products Regulatory Agency)